The diagnostic performance of neck ultrasound in follow-up of advanced stage differentiated thyroid cancer

被引:0
|
作者
Munro, Vicki [1 ]
Mustafa, Syed [2 ]
Siddiqi, Ferhan S. [1 ]
Rajaraman, Murali [4 ]
Costa, Andreu F. [3 ]
Imran, Syed Ali [1 ]
机构
[1] Dalhousie Univ, Dept Med, Div Endocrinol, 7N Victoria Bldg,1276 South Pk St, Halifax, NS B3H 2Y9, Canada
[2] Dalhousie Univ, Fac Med, Halifax, NS, Canada
[3] Dalhousie Univ, Dept Diagnost Radiol, Halifax, NS, Canada
[4] Dalhousie Univ, Dept Radiat Oncol, Halifax, NS, Canada
关键词
Thyroid cancer; Ultrasound; Thyroglobulin; Prognosis; Recurrence; CARCINOMA; SURVEILLANCE; NODULES; DISEASE;
D O I
10.1186/s13044-024-00213-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDifferentiated thyroid cancer (DTC) requires long-term follow-up due to the risk of delayed recurrence. Follow-up surveillance involves serial neck ultrasound (US) and thyroglobulin (Tg); however, the optimal frequency and diagnostic performance of neck US outside of specialized thyroid cancer centres in higher risk patients is not well defined. We sought to evaluate the diagnostic performance of US and serial Tg in advanced stage DTC.MethodsWe retrospectively reviewed our thyroid cancer database for patients with stage III and IV DTC from 2006 to 2018, total thyroidectomy, and at least 2 years follow-up to assess recurrence rates. Those with hemi-thyroidectomy or anti-Tg antibodies were excluded. Diagnostic performance of US and Tg were assessed using a composite reference standard of follow-up imaging and pathology. All relevant US were reviewed by a blinded expert radiologist for uniformity.ResultsOf 136 included patients (91 females, mean age 58.9), 26 (19%) had recurrence of DTC over median follow-up of 6.6 years (IQR 5.3-9.3). The sensitivity and specificity of US in diagnosing cervical recurrence were 73.3% (95% CI 0.51-0.96) and 68.3% (95% CI 0.60-0.77) based on historical reports, respectively, and 80% (95% CI 0.60-1.00) and 87.8% (95% CI 0.82-0.93) based on blinded expert review, respectively. Tg had a sensitivity of 95.5% (95% CI 0.89-1.0) and specificity of 96.2% (95% CI 0.92-0.99) in detecting cervical recurrence or distant metastases. False positive US findings on historical US and subsequent review occurred in 38 (28%) and 15 (11%) patients, respectively, while 5 (3.6%) had false positive Tg results.ConclusionSerial Tg has better sensitivity and specificity than US for detecting recurrence of advanced stage DTC. Furthermore, re-interpretation of abnormal findings using structured US reporting with a subspecialized reader may improve diagnostic performance of US and improve its utility in clinical care.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] A Risk-adapted Approach to Follow-up in Differentiated Thyroid Cancer
    Tarasova, Valentina D.
    Tuttle, R. Michael
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2016, 7 (01):
  • [32] FOLLOW-UP OF PATIENTS WITH DIFFERENTIATED THYROID CANCER (DTC) IN ROSARIO, ARGENTINA
    Anca, Lilian
    Dobry, Raquel
    Sanchez, Ariel
    REVISTA MEDICA DE ROSARIO, 2010, 76 (02): : 58 - 65
  • [33] Management and follow-up of thyroid cancer in pregnant women
    Gibelli, B.
    Zamperini, P.
    Proh, M.
    Giugliano, G.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2011, 31 (06) : 358 - 365
  • [34] Post-treatment follow-up of differentiated thyroid cancer.
    Mellière, D
    Berrahal, D
    Hindie, E
    Jeanguillaume, C
    Becquemin, JP
    Lange, F
    ANNALES DE CHIRURGIE, 2000, 125 (09): : 856 - 860
  • [35] Course and predictors of excellent response to therapy in patients with differentiated thyroid cancer at long-term follow-up
    Samargandy, Shaza A.
    Qorban, Ghofran N.
    Aljadani, Arwa K.
    Almufarji, Salihah S.
    Azab, Abdulrahman M.
    Merdad, Mazin A.
    Al-Hajeili, Marwan R.
    Samargandy, Saad J.
    SAUDI MEDICAL JOURNAL, 2024, 45 (02) : 139 - 146
  • [36] Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma
    Rodrigo, Juan Pablo
    Rinaldo, Alessandra
    Devaney, Kenneth O.
    Shaha, Ashok R.
    Ferlito, Alfio
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (11): : 1032 - 1039
  • [37] Ultrasound characteristics of cervical lesions in patients with radioiodine refractory differentiated thyroid cancer
    Gao, Luying
    Lin, Yansong
    Jiang, Yuxin
    Li, Hui
    Gao, Qiong
    Xi, Xuehua
    Wang, Ying
    Yang, Xiao
    Lai, Xingjian
    Zhu, Shenling
    Zhang, Xiaoyan
    Zhao, Ruina
    Zhang, Bo
    MEDICINE, 2019, 98 (45) : e17876
  • [38] Serum thyroglobulin measurement in the follow-up of patients treated for differentiated thyroid cancer
    Zucchelli, G.
    Iervasi, A.
    Ferdeghini, M.
    Iervasi, G.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 53 (05) : 482 - 489
  • [39] Effectiveness of Peripheral Thyrotropin Receptor mRNA in Follow-Up of Differentiated Thyroid Cancer
    Milas, Mira
    Barbosa, German F.
    Mitchell, Jamie
    Berber, Eren
    Siperstein, Allan
    Gupta, Manjula
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (02) : 473 - 480
  • [40] Iodine uptake in the chest in the follow-up of well-differentiated thyroid cancer
    Garcia Alonso, M. P.
    Balsa Breton, M. A.
    Paniagua Correa, C.
    Castillejos Rodriguez, L.
    Penin Gonzalez, F. J.
    Elviro Pena, R.
    Ortega Valle, A.
    Mariana Monguia, A.
    Vasquez Tineo, S. I.
    Mendoza Paulini, A.
    Pey Illera, C.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2011, 30 (01): : 24 - 28